MetLife Investment Management’s Assertio ASRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,128
Closed -$120K 2827
2023
Q3
$120K Buy
3,128
+1,177
+60% +$68.7K ﹤0.01% 2487
2023
Q2
$159K Buy
+1,951
New +$181K ﹤0.01% 2409
2019
Q3
Sell
-514
Closed -$106K 2334
2019
Q2
$106K Hold
514
﹤0.01% 2358
2019
Q1
$156K Hold
514
﹤0.01% 2109
2018
Q4
$111K Buy
514
+288
+127% +$86.5K ﹤0.01% 2245
2018
Q3
$79.8K Sell
226
-297
-57% -$130K ﹤0.01% 2357
2018
Q2
$209K Hold
523
﹤0.01% 1899
2018
Q1
$207K Hold
523
﹤0.01% 1871
2017
Q4
$253K Buy
+523
New +$203K ﹤0.01% 1805

Other funds holding ASRT

MetLife Investment Management's ASRT Position: Q4 2023 in Review

MetLife Investment Management sold out of Assertio (ASRT) in Q4 2023, closing a stake of 3,128 shares — an estimated $120K sold.

MetLife Investment Management first reported a position in ASRT in Q4 2017 and held it in 9 quarters. The position peaked at $253K in Q4 2017. 115 funds tracked by Wall St. Rank hold ASRT as of Q4 2023.

  • MetLife Investment Management reported no remaining Assertio position as of Q4 2023 after selling out during the quarter.
  • MetLife Investment Management sold 3,128 Assertio shares in Q4 2023, an estimated $120K.
  • MetLife Investment Management first reported a position in Assertio in Q4 2017 and held it in 9 quarters.
  • MetLife Investment Management's Assertio position peaked at $253K in Q4 2017.
  • 115 funds tracked by Wall St. Rank held Assertio as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.